NasdaqGS:PRVAHealthcare
Privia Health Group (PRVA) Margin Expansion To 1.1% Tests High P E Narrative
Privia Health Group (PRVA) just closed out FY 2025 with Q4 revenue of US$541.2 million and basic EPS of US$0.07, while trailing twelve month figures came in at US$2.1 billion of revenue and EPS of US$0.19. The company has seen revenue move from US$460.9 million in Q4 2024 to US$541.2 million in Q4 2025, with quarterly EPS shifting over that stretch from US$0.04 to US$0.07 and trailing net income reaching US$22.9 million. This sets up a results season where investors are likely to focus on...